Mari H. Dallas, MD
Mari H. Dallas, MD

Mari H. Dallas, MD

Assistant Member, St. Jude Faculty



MD – University of Pennsylvania School of Medicine (1999)

Honors & Awards

  • 2010  St. Baldrick’s Scholar
  • 2010  American Association of Cancer Research Career Development Award
  • 2009  Innovative Research in Cell Biology Research; Millipore
  • 2007  Aliana J. Enlow Scholar; National Marrow Donor Program
  • 2007  Special Fellow in Clinical Research; Leukemia & Lymphoma Society
  • 2007  New Investigator Award; UW Child Health Research Center
  • 1997  Research Scholar - University of Pennsylvania School of Medicine

Research Interests

  • Stem cell and T-cell development
  • Cord blood transplant
  • Infections and immune reconstitution after bone marrow transplant

Selected Publications

Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, Ware R, Leung W. Long Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease. Biol Blood Marrow Transplant Feb 14, 2013. pii: S1083-8791(13)00082-7. doi:10.1016/j.bbmt.2013.02.010.

Shook DR, Triplett BM, Srinivasan A, Hartford C, Dallas MH, Pillai A, Laver J, Leung W. Successful Allogeneic Hematopoietic Cell. Engraftment after a Minimal Conditioning Regimen in Children with Relapsed or Refractory Solid Tumors. Biol Blood Marrow Transplant Oct 9;(12):00401-6, 2012.

Triplett B, Wang C, Yang J, Dallas M, Hartford C, Howard V, Pillai A, Shook D, Srinivasan A, Laver J, Leung W, Effects of Conditioning Regimens and T Cell Depletion in Hematopoietic Cell Transplantation for Primary Immune Deficiency. Biol Blood Marrow Transplant Jul 27;(12):00303-5, 2010.

Leung W, Pui CH, Coustan-Smith E, Yang J, Pei D, Gan K, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Shook D, Rubnitz JE, Sandlund JT, Jeha S, Inaba H, Ribeiro RC, Handgretinger R, Laver JH, Campana D. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood April 19, 2012. doi: 10.1182/2012-02-409813.

Pillai A, Hartford C, Wang C, Pei D, Yang J, Srinivasan A, Triplett B, Dallas M, Leung W. Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia. Pediatr Transplant Sep;15(6):628-34, 2011.

Leung W, Yang J, Campana D, Pei D, Gan K, Rubnitz J, Sandlund J, Ribeiro R, Srinivasan A, Hartford C, Triplett B, Dallas M, Pillai A, Pui C, High Success of Hematopoietic Cell Transplantation Regardless of Donor Source in Children with Very-High-Risk Leukemia. Blood Jul 14;118(2):223-30, 2011.

Varnum-Finney B, Dallas M, Bernstein ID. Notch target Hes5 ensures appropriate Notch induced T vs. B-cell choices in the thymus. Blood 111(5): 2615-20, 2008.

Dallas M, Martin P, Varnum-Finney B, Bernstein ID. Enhanced T cell reconstitution with Ex-vivo Expanded Hematopoietic Progenitors Using Notch Ligand Delta1. Blood 109(8): 3579-87, 2007.

Dallas M, Varnum-Finney B, Bernstein ID. Density of the Notch Ligand Delta1 Determines Generation of B and T Cell Precursors from Hematopoietic Stem Cells. J Exp Med 201(9): 1361-6, 2005.

Last update: March 2013